Zobrazeno 1 - 10 of 10 344 pro vyhledávání: '"ATEZOLIZUMAB"'
2
Akademický článek
Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report.
Autor: Paczkowski, Freeman1 (AUTHOR) fpaczkow@uwo.ca, Raphael, Jacques2 (AUTHOR) claire.browne@lhsc.on.ca, Browne, Claire2 (AUTHOR)
Publikováno v: Current Oncology. Jul2024, Vol. 31 Issue 7, p3682-3689. 8p.
Zobrazit plný text záznamu
3
Akademický článek
Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada.
Autor: Chu, Quincy1 (AUTHOR) quincy.chu@albertahealthservices.ca, Sripada, Kaushik2 (AUTHOR) kaushik.sripada@roche.com, Vaselenak, Sarah2 (AUTHOR) sarah.vaselenak@roche.com, Jovanoski, Nick3 (AUTHOR) nick.jovanoski@roche.com, Arnold, Melina3 (AUTHOR) melina.arnold@roche.com
Publikováno v: Current Oncology. Jun2024, Vol. 31 Issue 6, p3301-3310. 10p.
Zobrazit plný text záznamu
4
Akademický článek
Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study.
Autor: Hata, Keiko1 (AUTHOR), Nakamura, Keina1 (AUTHOR), Maeda, Shinichiro1,2 (AUTHOR), Maeda, Makiko1,3 (AUTHOR), Fujio, Yasushi4,5 (AUTHOR), Hirobe, Sachiko1,2,3 (AUTHOR) hirobe.sachiko.phs@osaka-u.ac.jp
Publikováno v: Clinics & Practice. Apr2024, Vol. 14 Issue 2, p377-387. 11p.
Zobrazit plný text záznamu
5
Akademický článek
The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study.
Autor: Choi, Myeong Geun1,2 (AUTHOR), Kim, Yeon Joo3 (AUTHOR), Lee, Jae Cheol4 (AUTHOR), Ji, Wonjun1 (AUTHOR), Oh, In-Jae5 (AUTHOR), Lee, Sung Yong6 (AUTHOR), Yoon, Seong Hoon7 (AUTHOR), Lee, Shin Yup8 (AUTHOR), Lee, Jeong Eun9 (AUTHOR), Kim, Eun Young10 (AUTHOR), Choi, Chang-Min1,4 (AUTHOR) ccm@amc.seoul.kr
Publikováno v: Cancer Research & Treatment. Apr2024, Vol. 56 Issue 2, p422-429. 8p.
Zobrazit plný text záznamu
6
Akademický článek
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.
Autor: Nakabori, Tasuku1 (AUTHOR) tasuku.nakabori@oici.jp, Higashi, Sena1 (AUTHOR), Abe, Yutaro1 (AUTHOR), Mukai, Kaori1 (AUTHOR), Ikawa, Toshiki2 (AUTHOR), Konishi, Koji2 (AUTHOR), Maeda, Noboru3 (AUTHOR), Nakanishi, Katsuyuki3 (AUTHOR), Hasegawa, Shinichiro4 (AUTHOR), Wada, Hiroshi4 (AUTHOR), Ohkawa, Kazuyoshi1 (AUTHOR)
Publikováno v: Current Oncology. Mar2024, Vol. 31 Issue 3, p1543-1555. 13p.
Zobrazit plný text záznamu
7
Akademický článek
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Autor: Hatanaka, Takeshi1 (AUTHOR) hatanaka@qk9.so‐net.ne.jp, Kakizaki, Satoru2,3 (AUTHOR), Hiraoka, Atsushi4 (AUTHOR), Tada, Toshifumi5 (AUTHOR), Hirooka, Masashi6 (AUTHOR), Kariyama, Kazuya7 (AUTHOR), Tani, Joji8 (AUTHOR), Atsukawa, Masanori9 (AUTHOR), Takaguchi, Koichi10 (AUTHOR), Itobayashi, Ei11 (AUTHOR), Fukunishi, Shinya12 (AUTHOR), Tsuji, Kunihiko13 (AUTHOR), Ishikawa, Toru14 (AUTHOR), Tajiri, Kazuto15 (AUTHOR), Ochi, Hironori16 (AUTHOR), Yasuda, Satoshi17 (AUTHOR), Toyoda, Hidenori17 (AUTHOR), Ogawa, Chikara18 (AUTHOR), Yokohama, Keisuke19 (AUTHOR), Nishikawa, Hiroki19 (AUTHOR)
Publikováno v: Cancer Medicine. Dec2023, Vol. 12 Issue 24, p21680-21693. 14p.
Zobrazit plný text záznamu
8
Akademický článek
Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
Autor: Villalobos, Alexander1 (AUTHOR) a.villalobos@unc.edu, Dabbous, Howard Hussein2 (AUTHOR) hdabbous@dmc.org, Little, Olivia3 (AUTHOR) olivia.lekuang.little@live.mercer.edu, Gbolahan, Olumide Babajide4 (AUTHOR) ogbolah@emory.edu, Akce, Mehmet5 (AUTHOR) makce@uabmc.edu, Lilly, Meghan Allegra2 (AUTHOR) meghan.lilly@emory.edu, Bercu, Zachary2 (AUTHOR) zachary.louis.bercu@emory.edu, Kokabi, Nima1 (AUTHOR)
Publikováno v: Current Oncology. Dec2023, Vol. 30 Issue 12, p10100-10110. 11p.
Zobrazit plný text záznamu
9
Akademický článek
Recommencement of atezolizumab with associated pulmonary sarcoid‐like reaction.
Autor: Tam, Khai1 (AUTHOR) he164049@health.wa.gov.au, Wallace, Michael1 (AUTHOR), Mulrennan, Siobhain1 (AUTHOR)
Publikováno v: Respirology Case Reports. May2024, Vol. 12 Issue 5, p1-3. 3p.
Zobrazit plný text záznamu
10
Akademický článek
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Autor: Roussot, Nicolas1,2,3,4 (AUTHOR), Fumet, Jean-David1,2 (AUTHOR) jdfumet@cgfl.fr, Limagne, Emeric2,3,4,5 (AUTHOR), Thibaudin, Marion2,4,5 (AUTHOR), Hervieu, Alice1 (AUTHOR), Hennequin, Audrey1 (AUTHOR), Zanetta, Sylvie1 (AUTHOR), Dalens, Lorraine1 (AUTHOR), Fourrier, Théo1 (AUTHOR), Galland, Loick1 (AUTHOR), Jacob, Pierre1 (AUTHOR), Bertaut, Aurélie6 (AUTHOR), Rederstorff, Emilie6 (AUTHOR), Chevalier, Cédric7 (AUTHOR), Ghirardi, Sarah7 (AUTHOR), Gilbert, Elodie7 (AUTHOR), Khoukaz, Azzat7 (AUTHOR), Martin, Etienne7 (AUTHOR), Nicolet, Constance7 (AUTHOR), Quivrin, Magali7 (AUTHOR)
Publikováno v: BMC Cancer. 11/9/2023, Vol. 23 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje